Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Angiogenic Proteins"" wg kryterium: Temat


Tytuł :
Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2.
Autorzy :
Si W; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Zhou B; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Xie W; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Li H; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Li K; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Li S; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Deng W; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Shi P; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Yuan C; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Ke T; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Ren X; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Tu X; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Zeng X; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China.
Weigelt B; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Rubin BP; Robert J. Tomsich Pathology & Laboratory Medicine Institute, USA; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Chen Q; Cardiovascular and Metabolic Sciences, Lerner Research Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, 44195, USA; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, 44195, USA. Electronic address: .
Xu C; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China. Electronic address: .
Wang QK; Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Jan 28; Vol. 497, pp. 28-40. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation, Neoplastic*
RNA Processing, Post-Transcriptional*
Angiogenic Proteins/*metabolism
Biomarkers, Tumor/*metabolism
Colonic Neoplasms/*pathology
Proto-Oncogene Proteins c-mdm2/*metabolism
Tumor Suppressor Protein p53/*metabolism
Angiogenic Proteins/genetics ; Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Colonic Neoplasms/genetics ; Colonic Neoplasms/metabolism ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Mutation ; Prognosis ; Proto-Oncogene Proteins c-mdm2/genetics ; Survival Rate ; Tumor Cells, Cultured ; Tumor Suppressor Protein p53/chemistry ; Tumor Suppressor Protein p53/genetics ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Photobiomodulation effect on angiogenic proteins produced and released by dental pulp cells.
Autorzy :
Vitor LLR; Department of Pediatric Dentistry, University of Sacred Heart, Rua Irmã Arminda, 10-50, Bauru, São Paulo, 17011-160, Brazil. .
Bergamo MTOP; Department of Pediatric Dentistry, Orthodontics, and Public Health, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Lourenço-Neto N; Department of Pediatric Dentistry, Orthodontics, and Public Health, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Sakai VT; Department of Clinics and Surgery, School of Dentistry, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil.
Oliveira RC; Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Cruvinel T; Department of Pediatric Dentistry, Orthodontics, and Public Health, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Rios D; Department of Pediatric Dentistry, Orthodontics, and Public Health, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Garlet GP; Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Santos CF; Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Machado MAAM; Department of Pediatric Dentistry, Orthodontics, and Public Health, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Oliveira TM; Department of Pediatric Dentistry, Orthodontics, and Public Health, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, Brazil.
Pokaż więcej
Źródło :
Clinical oral investigations [Clin Oral Investig] 2020 Dec; Vol. 24 (12), pp. 4343-4354. Date of Electronic Publication: 2020 Apr 24.
Typ publikacji :
Journal Article
MeSH Terms :
Angiogenic Proteins*
Dental Pulp*
Cells, Cultured ; Female ; Humans ; Placenta Growth Factor ; Vascular Endothelial Growth Factor A
Czasopismo naukowe
Tytuł :
Prognostic significance of vasohibin-1 and vasohibin-2 immunohistochemical expression in gastric cancer.
Autorzy :
Hara H; Department of Gastroenterological Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Ozawa S; Department of Gastroenterological Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan. .
Ninomiya Y; Department of Gastroenterological Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Yamamoto M; Department of Gastroenterological Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Ogimi M; Department of Gastroenterological Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Nabeshima K; Department of Gastroenterological Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Nakamura K; Department of Gastroenterological Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Kajiwara H; Department of Pathology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Nakamura N; Department of Pathology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1143, Japan.
Sato Y; Department of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-9575, Japan.
Pokaż więcej
Źródło :
Surgery today [Surg Today] 2020 Nov; Vol. 50 (11), pp. 1530-1543. Date of Electronic Publication: 2020 Jun 03.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression*
Angiogenic Proteins/*metabolism
Biomarkers, Tumor/*genetics
Biomarkers, Tumor/*metabolism
Cell Cycle Proteins/*metabolism
Stomach Neoplasms/*diagnosis
Stomach Neoplasms/*genetics
Aged ; Angiogenic Proteins/genetics ; Cell Cycle Proteins/genetics ; Disease-Free Survival ; Female ; Humans ; Immunohistochemistry ; Male ; Neoplasm Recurrence, Local/genetics ; Neovascularization, Pathologic/genetics ; Prognosis ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Defining Endothelial Cell-Derived Factors That Promote Pericyte Recruitment and Capillary Network Assembly.
Autorzy :
Kemp SS; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa.
Aguera KN; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa.
Cha B; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa.
Davis GE; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa.
Pokaż więcej
Źródło :
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2020 Nov; Vol. 40 (11), pp. 2632-2648. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Video-Audio Media
MeSH Terms :
Cell Movement*/drug effects
Neovascularization, Physiologic*/drug effects
Paracrine Communication*/drug effects
Angiogenic Proteins/*metabolism
Brain/*blood supply
Capillaries/*metabolism
Human Umbilical Vein Endothelial Cells/*metabolism
Pericytes/*metabolism
Angiogenic Proteins/pharmacology ; Becaplermin/metabolism ; Capillaries/cytology ; Capillaries/drug effects ; Cell Proliferation ; Cells, Cultured ; Coculture Techniques ; Endothelin-1/metabolism ; Heparin-binding EGF-like Growth Factor/metabolism ; Human Umbilical Vein Endothelial Cells/drug effects ; Humans ; Lymphokines/metabolism ; Pericytes/drug effects ; Platelet-Derived Growth Factor/metabolism ; Signal Transduction ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Tytuł :
Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage.
Autorzy :
Gerhart J; Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States of America.
Bowers J; Genisphere, LLC, Hatfield, PA, United States of America.
Gugerty L; Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States of America.
Gerhart C; Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States of America.
Martin M; Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States of America.
Abdalla F; Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States of America.
Bravo-Nuevo A; Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States of America.
Sullivan JT; Integral Molecular, Philadelphia, PA, United States of America.
Rimkunas R; Integral Molecular, Philadelphia, PA, United States of America.
Albertus A; Integral Molecular, Philadelphia, PA, United States of America.
Casta L; Genisphere, LLC, Hatfield, PA, United States of America.
Getts L; Genisphere, LLC, Hatfield, PA, United States of America.
Getts R; Genisphere, LLC, Hatfield, PA, United States of America.
George-Weinstein M; Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Jul 02; Vol. 15 (7), pp. e0234792. Date of Electronic Publication: 2020 Jul 02 (Print Publication: 2020).
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Angiogenic Proteins/*biosynthesis
Myofibroblasts/*metabolism
Receptors, G-Protein-Coupled/*biosynthesis
Amino Acid Substitution ; Angiogenic Proteins/chemistry ; Angiogenic Proteins/genetics ; Angiogenic Proteins/immunology ; Animals ; Antibodies, Monoclonal/immunology ; Antibody Specificity ; Antigen-Antibody Reactions ; Brain/cytology ; Carrier Proteins/analysis ; Cell Lineage ; Epitopes/immunology ; Eye Proteins/biosynthesis ; Eye Proteins/chemistry ; Eye Proteins/genetics ; Eye Proteins/immunology ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Models, Molecular ; Muscle Development ; MyoD Protein/analysis ; Organ Specificity ; Protein Conformation ; Protein Domains ; Rabbits ; Rats, Sprague-Dawley ; Receptors, G-Protein-Coupled/chemistry ; Receptors, G-Protein-Coupled/genetics ; Receptors, G-Protein-Coupled/immunology ; Repetitive Sequences, Amino Acid ; Skin/cytology ; Species Specificity ; Tattooing ; Young Adult
Czasopismo naukowe
Tytuł :
The 3' Untranslated Region Protects the Heart from Angiotensin II-Induced Cardiac Dysfunction via AGGF1 Expression.
Autorzy :
Ding L; Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, China.
Lu S; Department of Pharmacology, University of California, Davis, Davis, CA, USA.
Zhou Y; Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
Lyu D; Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
Ouyang C; Department of Pharmacy, Hubei Key Laboratory of Diabetes and Angiopathy, Hubei University of Science and Technology, Xianning 437100, China.
Ma Z; NHC Key Laboratory of Hormones and Development (Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin 300134, China.
Lu Q; Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China. Electronic address: .
Pokaż więcej
Źródło :
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2020 Apr 08; Vol. 28 (4), pp. 1119-1132. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Angiogenic Proteins/*genetics
Angiotensin II/*adverse effects
Genetic Vectors/*administration & dosage
Heart Diseases/*prevention & control
MicroRNAs/*genetics
Myeloid Cell Leukemia Sequence 1 Protein/*genetics
Myocytes, Cardiac/*cytology
3' Untranslated Regions ; Angiogenic Proteins/metabolism ; Animals ; Cells, Cultured ; Dependovirus/genetics ; Disease Models, Animal ; Genetic Therapy ; HEK293 Cells ; Heart Diseases/chemically induced ; Heart Diseases/physiopathology ; Heart Function Tests ; Humans ; Male ; Mice ; Myeloid Cell Leukemia Sequence 1 Protein/metabolism ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/metabolism
Czasopismo naukowe
Tytuł :
Vaccarin Regulates Diabetic Chronic Wound Healing through FOXP2/AGGF1 Pathways.
Autorzy :
Liu Y; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Sun J; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Ma X; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Li S; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Ai M; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Xu F; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Qiu L; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Mar 13; Vol. 21 (6). Date of Electronic Publication: 2020 Mar 13.
Typ publikacji :
Journal Article
MeSH Terms :
Wound Healing*
Angiogenic Proteins/*metabolism
Diabetes Mellitus, Experimental/*complications
Flavonoids/*therapeutic use
Forkhead Transcription Factors/*metabolism
Glycosides/*therapeutic use
Pressure Ulcer/*drug therapy
Repressor Proteins/*metabolism
Angiogenic Proteins/genetics ; Animals ; Cell Movement ; Cell Proliferation ; Cells, Cultured ; Endothelial Cells/drug effects ; Endothelial Cells/metabolism ; Endothelial Cells/physiology ; Endothelium, Vascular/cytology ; Flavonoids/pharmacology ; Forkhead Transcription Factors/genetics ; Glycosides/pharmacology ; Humans ; MAP Kinase Signaling System ; Male ; Mice ; Mice, Inbred C57BL ; Pressure Ulcer/etiology ; Pressure Ulcer/metabolism ; Repressor Proteins/genetics
Czasopismo naukowe
Tytuł :
Evolutionary Divergence of Enzymatic Mechanisms for Tubulin Detyrosination.
Autorzy :
van der Laan S; Tubulin Code Team, Institute of Human Genetics (IGH), CNRS-Université Montpellier, 141 rue de la Cardonille, 34293 Montpellier Cedex 5, France. Electronic address: .
Lévêque MF; Université Montpellier-CNRS, 'MiVEGEC,' Faculté de Medicine and Centre Hospitalier Universitaire, 39 avenue Charles Flahault, 34295 Montpellier Cedex 5, France. Electronic address: .
Marcellin G; Tubulin Code Team, Institute of Human Genetics (IGH), CNRS-Université Montpellier, 141 rue de la Cardonille, 34293 Montpellier Cedex 5, France.
Vezenkov L; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS-Université Montpellier-ENSCM, 34093 Montpellier Cedex 5, France.
Lannay Y; Tubulin Code Team, Institute of Human Genetics (IGH), CNRS-Université Montpellier, 141 rue de la Cardonille, 34293 Montpellier Cedex 5, France.
Dubra G; Tubulin Code Team, Institute of Human Genetics (IGH), CNRS-Université Montpellier, 141 rue de la Cardonille, 34293 Montpellier Cedex 5, France.
Bompard G; Tubulin Code Team, Institute of Human Genetics (IGH), CNRS-Université Montpellier, 141 rue de la Cardonille, 34293 Montpellier Cedex 5, France.
Ovejero S; Tubulin Code Team, Institute of Human Genetics (IGH), CNRS-Université Montpellier, 141 rue de la Cardonille, 34293 Montpellier Cedex 5, France.
Urbach S; Functional Proteomics Platform (FPP), IGF, Université Montpellier, CNRS, INSERM, Montpellier, France.
Burgess A; ANZAC Research Institute, Gate 3 Hospital Rd., Concord, Sydney, NSW 2139, Australia; The University of Sydney Concord Clinical School, Faculty of Medicine and Health, Sydney, NSW, Australia.
Amblard M; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS-Université Montpellier-ENSCM, 34093 Montpellier Cedex 5, France.
Sterkers Y; Université Montpellier-CNRS, 'MiVEGEC,' Faculté de Medicine and Centre Hospitalier Universitaire, 39 avenue Charles Flahault, 34295 Montpellier Cedex 5, France.
Bastien P; Université Montpellier-CNRS, 'MiVEGEC,' Faculté de Medicine and Centre Hospitalier Universitaire, 39 avenue Charles Flahault, 34295 Montpellier Cedex 5, France.
Rogowski K; Tubulin Code Team, Institute of Human Genetics (IGH), CNRS-Université Montpellier, 141 rue de la Cardonille, 34293 Montpellier Cedex 5, France. Electronic address: .
Pokaż więcej
Źródło :
Cell reports [Cell Rep] 2019 Dec 17; Vol. 29 (12), pp. 4159-4171.e6.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biological Evolution*
Angiogenic Proteins/*metabolism
Carrier Proteins/*metabolism
Cell Cycle Proteins/*metabolism
Trypanosoma brucei brucei/*metabolism
Tyrosine/*metabolism
Angiogenic Proteins/chemistry ; Angiogenic Proteins/genetics ; Carrier Proteins/chemistry ; Carrier Proteins/genetics ; Cell Cycle Proteins/chemistry ; Cell Cycle Proteins/genetics ; Crystallography, X-Ray ; Flagella/metabolism ; HEK293 Cells ; Humans ; Microtubules/metabolism ; Mitosis ; Phylogeny ; Protein Conformation ; Protein Processing, Post-Translational ; Trypanosoma brucei brucei/genetics ; Trypanosoma brucei brucei/growth & development ; Tyrosine/chemistry ; Tyrosine/genetics
Czasopismo naukowe
Tytuł :
Sustained delivery of the angiogenic QK peptide through the use of polyglutamate domains to control peptide release from bone graft materials.
Autorzy :
Pensa NW; Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
Curry AS; Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
Reddy MS; School of Dentistry, University of California, San Francisco, California.
Bellis SL; Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama.
Pokaż więcej
Źródło :
Journal of biomedical materials research. Part A [J Biomed Mater Res A] 2019 Dec; Vol. 107 (12), pp. 2764-2773. Date of Electronic Publication: 2019 Aug 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Angiogenesis Inducing Agents/*administration & dosage
Angiogenic Proteins/*administration & dosage
Bone Substitutes/*chemistry
Delayed-Action Preparations/*chemistry
Durapatite/*chemistry
Polyglutamic Acid/*administration & dosage
Angiogenesis Inducing Agents/chemistry ; Angiogenesis Inducing Agents/pharmacology ; Angiogenic Proteins/chemistry ; Angiogenic Proteins/pharmacology ; Drug Liberation ; Human Umbilical Vein Endothelial Cells ; Humans ; Neovascularization, Physiologic/drug effects ; Polyglutamic Acid/chemistry ; Polyglutamic Acid/pharmacology ; Vascular Endothelial Growth Factor A/administration & dosage ; Vascular Endothelial Growth Factor A/chemistry ; Vascular Endothelial Growth Factor A/pharmacology
Czasopismo naukowe
Tytuł :
Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and III.
Autorzy :
Chatterjee S; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.) .
Mukherjee S; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Sankara Sivaprasad LVJ; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Naik T; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Gautam SS; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Murali BV; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Hadambar AA; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Gunti GR; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Kuchibhotla V; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Deyati A; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Basavanthappa S; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Ramarao M; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Mariappan TT; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Zinker BA; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Zhang Y; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Sinz M; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Shen H; Pharmaceutical Candidate Optimization (S.C., S.S.L.V.J., T.N., S.S.G., B.V.M.) and Discovery and Translational Medicine (S.M., A.A.H., G.R.G., V.K., A.D., S.B.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India; Pharmaceutical Candidate Optimization (T.T.M.) and Discovery and Translational Medicine, Bristol-Myers Squibb India Pvt. Ltd. (M.R.), Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India; BMS Fibrosis Drug Discovery, Research and Early Development, Princeton, New Jersey (B.A.Z.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Princeton, New Jersey (Y.Z., M.S., H.S.).
Pokaż więcej
Źródło :
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2021 Jan; Vol. 376 (1), pp. 29-39. Date of Electronic Publication: 2020 Oct 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Coproporphyrins/*metabolism
Multidrug Resistance-Associated Proteins/*metabolism
Non-alcoholic Fatty Liver Disease/*metabolism
Angiogenic Proteins/genetics ; Angiogenic Proteins/metabolism ; Animals ; Coproporphyrins/blood ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Multidrug Resistance-Associated Proteins/genetics ; Protein Binding ; Rats ; Rats, Sprague-Dawley ; Sf9 Cells ; Spodoptera
Czasopismo naukowe
Tytuł :
Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair.
Autorzy :
Madonna R; Department of Internal Medicine, McGovern School of Medicine, The University of Texas Health Science Center at Houston, Houston, TX, United States of America; Chair of Cardiology, Department of Surgical, Medical and Molecular Pathology, University of Pisa, Pisa, Italy. Electronic address: .
Pieragostino D; Center of Aging Sciences and Translational Medicine - CESI-Met and Institute of Cardiology, 'G. D'Annunzio' University, Chieti-Pescara, Chieti, Italy; Department of Medical, Oral and Biotechnological Sciences, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Rossi C; Center of Aging Sciences and Translational Medicine - CESI-Met and Institute of Cardiology, 'G. D'Annunzio' University, Chieti-Pescara, Chieti, Italy; Department of Medical, Oral and Biotechnological Sciences, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Guarnieri S; Center of Aging Sciences and Translational Medicine - CESI-Met and Institute of Cardiology, 'G. D'Annunzio' University, Chieti-Pescara, Chieti, Italy; Department of Neuroscience, Imaging and Clinical Sciences, 'G. d'Annunzio' University, Chieti-Pescara and StemTeCh Group, Chieti, Italy.
Nagy CT; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
Giricz Z; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; Pharmahungary Group, Szeged, Hungary.
Ferdinandy P; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; Pharmahungary Group, Szeged, Hungary.
Del Boccio P; Center of Aging Sciences and Translational Medicine - CESI-Met and Institute of Cardiology, 'G. D'Annunzio' University, Chieti-Pescara, Chieti, Italy; Department of Pharmacy, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Mariggiò MA; Center of Aging Sciences and Translational Medicine - CESI-Met and Institute of Cardiology, 'G. D'Annunzio' University, Chieti-Pescara, Chieti, Italy; Department of Neuroscience, Imaging and Clinical Sciences, 'G. d'Annunzio' University, Chieti-Pescara and StemTeCh Group, Chieti, Italy.
Geng YJ; Department of Internal Medicine, McGovern School of Medicine, The University of Texas Health Science Center at Houston, Houston, TX, United States of America.
De Caterina R; Chair of Cardiology, Department of Surgical, Medical and Molecular Pathology, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło :
Vascular pharmacology [Vascul Pharmacol] 2020 Dec; Vol. 135, pp. 106807. Date of Electronic Publication: 2020 Oct 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mesenchymal Stem Cell Transplantation*
Regeneration*
Mesenchymal Stem Cells/*enzymology
Myocardial Infarction/*surgery
Myocardium/*metabolism
Nuclear Proteins/*metabolism
Telomerase/*metabolism
Trans-Activators/*metabolism
Angiogenic Proteins/genetics ; Angiogenic Proteins/metabolism ; Animals ; Cells, Cultured ; Disease Models, Animal ; Extracellular Vesicles/enzymology ; Extracellular Vesicles/transplantation ; Fibrosis ; Green Fluorescent Proteins/genetics ; Green Fluorescent Proteins/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Myocardial Infarction/enzymology ; Myocardial Infarction/pathology ; Myocardial Infarction/physiopathology ; Myocardium/pathology ; Nuclear Proteins/genetics ; Paracrine Communication ; Recovery of Function ; Signal Transduction ; Telomerase/genetics ; Trans-Activators/genetics
Czasopismo naukowe
Tytuł :
Angiogenic protein synthesis after photobiomodulation therapy on SHED: a preliminary study.
Autorzy :
Oliveira Prado Bergamo MT; Department of Pediatric Dentistry, Orthodontics and Public Health, Bauru School of Dentistry, University of São Paulo, Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, São Paulo, 17012-901, Brazil.
Vitor LLR; Department of Pediatric Dentistry, Orthodontics and Public Health, Bauru School of Dentistry, University of São Paulo, Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, São Paulo, 17012-901, Brazil.
Lopes NM; Department of Biology Science, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, 17012-901, Brazil.
Lourenço Neto N; Department of Pediatric Dentistry, Orthodontics and Public Health, Bauru School of Dentistry, University of São Paulo, Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, São Paulo, 17012-901, Brazil.
Dionísio TJ; Department of Biology Science, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, 17012-901, Brazil.
Oliveira RC; Department of Biology Science, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, 17012-901, Brazil.
Oliveira Rodini C; Department of Biology Science, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, 17012-901, Brazil.
Santos CF; Department of Biology Science, Bauru School of Dentistry, University of São Paulo, Bauru, São Paulo, 17012-901, Brazil.
Machado MAAM; Department of Pediatric Dentistry, Orthodontics and Public Health, Bauru School of Dentistry, University of São Paulo, Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, São Paulo, 17012-901, Brazil.
Oliveira TM; Department of Pediatric Dentistry, Orthodontics and Public Health, Bauru School of Dentistry, University of São Paulo, Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, São Paulo, 17012-901, Brazil. .
Pokaż więcej
Źródło :
Lasers in medical science [Lasers Med Sci] 2020 Dec; Vol. 35 (9), pp. 1909-1918. Date of Electronic Publication: 2020 Feb 14.
Typ publikacji :
Journal Article
MeSH Terms :
Low-Level Light Therapy*
Angiogenic Proteins/*biosynthesis
Tooth, Deciduous/*radiation effects
Biomarkers/metabolism ; Cell Proliferation/radiation effects ; Cell Survival/radiation effects ; Cells, Cultured ; Child ; Child, Preschool ; Dental Pulp/cytology ; Humans ; Lasers, Semiconductor ; Stem Cells/cytology
Czasopismo naukowe
Tytuł :
Angiogenesis-Related Genes in Endothelial Progenitor Cells May Be Involved in Sickle Cell Stroke.
Autorzy :
Ito MT; Center for Molecular Biology and Genetic Engineering University of Campinas-UNICAMP Campinas São Paulo Brazil.
da Silva Costa SM; Center for Molecular Biology and Genetic Engineering University of Campinas-UNICAMP Campinas São Paulo Brazil.
Baptista LC; Center for Molecular Biology and Genetic Engineering University of Campinas-UNICAMP Campinas São Paulo Brazil.
Carvalho-Siqueira GQ; Center for Molecular Biology and Genetic Engineering University of Campinas-UNICAMP Campinas São Paulo Brazil.
Albuquerque DM; Hematology and Hemotherapy Center University of Campinas-UNICAMP Campinas São Paulo Brazil.
Rios VM; Center for Molecular Biology and Genetic Engineering University of Campinas-UNICAMP Campinas São Paulo Brazil.
Ospina-Prieto S; Hematology and Hemotherapy Center University of Campinas-UNICAMP Campinas São Paulo Brazil.
Saez RC; Hematology and Hemotherapy Center University of Campinas-UNICAMP Campinas São Paulo Brazil.
Vieira KP; Hematology and Hemotherapy Center University of Campinas-UNICAMP Campinas São Paulo Brazil.
Cendes F; Neuroimaging Laboratory Department of Neurology University of Campinas, UNICAMP Campinas São Paulo Brazil.
Ozelo MC; Hematology and Hemotherapy Center University of Campinas-UNICAMP Campinas São Paulo Brazil.
Saad STO; Hematology and Hemotherapy Center University of Campinas-UNICAMP Campinas São Paulo Brazil.
Costa FF; Hematology and Hemotherapy Center University of Campinas-UNICAMP Campinas São Paulo Brazil.
Melo MB; Center for Molecular Biology and Genetic Engineering University of Campinas-UNICAMP Campinas São Paulo Brazil.
Pokaż więcej
Źródło :
Journal of the American Heart Association [J Am Heart Assoc] 2020 Feb 04; Vol. 9 (3), pp. e014143. Date of Electronic Publication: 2020 Feb 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neovascularization, Physiologic*/genetics
Anemia, Sickle Cell/*metabolism
Angiogenic Proteins/*metabolism
Endothelial Progenitor Cells/*metabolism
Matrix Metalloproteinase 1/*metabolism
Stroke/*etiology
Adult ; Anemia, Sickle Cell/complications ; Anemia, Sickle Cell/diagnosis ; Anemia, Sickle Cell/genetics ; Angiogenic Proteins/genetics ; Case-Control Studies ; Endothelial Progenitor Cells/pathology ; Female ; Humans ; Male ; Matrix Metalloproteinase 1/genetics ; Middle Aged ; Stroke/diagnostic imaging ; Stroke/genetics ; Stroke/metabolism ; Transcriptome
Czasopismo naukowe
Tytuł :
Pulsed Electromagnetic Fields Increase Angiogenesis and Improve Cardiac Function After Myocardial Ischemia in Mice.
Autorzy :
Peng L; Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University.; Key Laboratory of Rehabilitation Medicine in Sichuan Province.
Fu C; Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University.; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University.
Liang Z; Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University.; Key Laboratory of Rehabilitation Medicine in Sichuan Province.
Zhang Q; Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University.; Key Laboratory of Rehabilitation Medicine in Sichuan Province.
Xiong F; Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University.; Key Laboratory of Rehabilitation Medicine in Sichuan Province.
Chen L; Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University.; Key Laboratory of Rehabilitation Medicine in Sichuan Province.
He C; Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University.; Key Laboratory of Rehabilitation Medicine in Sichuan Province.
Wei Q; Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University.; Key Laboratory of Rehabilitation Medicine in Sichuan Province.
Pokaż więcej
Źródło :
Circulation journal : official journal of the Japanese Circulation Society [Circ J] 2020 Jan 24; Vol. 84 (2), pp. 186-193. Date of Electronic Publication: 2020 Jan 09.
Typ publikacji :
Journal Article
MeSH Terms :
Electromagnetic Fields*
Magnetic Field Therapy*
Neovascularization, Physiologic*
Ventricular Function, Left*
Angiogenic Proteins/*metabolism
Myocardial Infarction/*therapy
Myocardium/*metabolism
Angiogenic Proteins/genetics ; Animals ; Disease Models, Animal ; Fibroblast Growth Factor 2/genetics ; Fibroblast Growth Factor 2/metabolism ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Mice, Inbred C57BL ; Myocardial Infarction/metabolism ; Myocardial Infarction/pathology ; Myocardial Infarction/physiopathology ; Myocardium/pathology ; Nitric Oxide Synthase Type III/metabolism ; Phosphorylation ; Proto-Oncogene Proteins c-akt/metabolism ; Recovery of Function ; Signal Transduction ; Vascular Endothelial Growth Factor A/genetics ; Vascular Endothelial Growth Factor A/metabolism ; Vascular Endothelial Growth Factor Receptor-2/metabolism
Czasopismo naukowe
Tytuł :
Expression of angiogenic factor with G patch and FHA domains 1 (AGGF1) in placenta from patients with preeclampsia.
Autorzy :
An LF; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Chi SQ; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Zhang J; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Wang HB; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Ouyang WX; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .
Pokaż więcej
Źródło :
Folia histochemica et cytobiologica [Folia Histochem Cytobiol] 2020; Vol. 58 (2), pp. 83-89. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
Angiogenic Proteins/*metabolism
Pre-Eclampsia/*metabolism
Adult ; Angiogenic Proteins/genetics ; Female ; Humans ; Placenta/pathology ; Pre-Eclampsia/pathology ; Pregnancy ; RNA, Messenger/metabolism ; Trophoblasts/metabolism
Czasopismo naukowe
Tytuł :
EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.
Autorzy :
Zhang H; Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery and Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA.; Department of Neurosurgery, Xiangya Hospital and School of Medicine, Central South University, 410013, Changsha, Hunan, P.R. China.
Zhu D; Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery and Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA.
Zhang Z; Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery and Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA.
Kaluz S; Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery and Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA.
Yu B; Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery and Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA.
Devi NS; Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery and Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA.
Olson JJ; Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery and Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA.
Van Meir EG; Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery and Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA. .; Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA. .; Department of Hematology & Medical Oncology, School of Medicine, Emory University, Atlanta, GA, 30322, USA. .; Department of Neurosurgery and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham (UAB), WTI 520E, 1720 2nd Ave., South Birmingham, AL, 35294, USA. .
Pokaż więcej
Źródło :
Oncogene [Oncogene] 2020 Jan; Vol. 39 (5), pp. 1041-1048. Date of Electronic Publication: 2019 Oct 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Epigenesis, Genetic*
Angiogenic Proteins/*genetics
Enhancer of Zeste Homolog 2 Protein/*metabolism
Medulloblastoma/*pathology
Receptors, G-Protein-Coupled/*genetics
Tumor Suppressor Protein p53/*genetics
Angiogenic Proteins/deficiency ; CCAAT-Enhancer-Binding Protein-beta/metabolism ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cell Transformation, Neoplastic ; Gene Silencing ; Histones/metabolism ; Humans ; Methylation ; Peptide Fragments/metabolism ; Receptors, G-Protein-Coupled/deficiency ; Sialoglycoproteins/metabolism
Czasopismo naukowe
Tytuł :
AGGF1 inhibits the expression of inflammatory mediators and promotes angiogenesis in dental pulp cells.
Autorzy :
Shen S; Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, No. 44-1 Wenhua Road West, 250012, Jinan, People's Republic of China.
Shang L; Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, No. 44-1 Wenhua Road West, 250012, Jinan, People's Republic of China.
Liu H; Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, No. 44-1 Wenhua Road West, 250012, Jinan, People's Republic of China.
Liang Q; Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, No. 44-1 Wenhua Road West, 250012, Jinan, People's Republic of China.
Liang W; Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, No. 44-1 Wenhua Road West, 250012, Jinan, People's Republic of China.
Ge S; Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, No. 44-1 Wenhua Road West, 250012, Jinan, People's Republic of China. .
Pokaż więcej
Źródło :
Clinical oral investigations [Clin Oral Investig] 2021 Feb; Vol. 25 (2), pp. 581-592. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Journal Article
MeSH Terms :
Dental Pulp*/metabolism
Inflammation Mediators*
Angiogenic Proteins ; Humans ; Lipopolysaccharides/pharmacology ; NF-kappa B/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł :
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Autorzy :
Ria R; Operative Unit of Internal Medicine 'G. Baccelli', Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, Italy. Electronic address: .
Prete F; Academic General Surgery Unit, Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, (BA), Italy.
Melaccio A; Operative Unit of Internal Medicine 'G. Baccelli', Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, Italy.
Di Meo G; Academic General Surgery Unit, Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, (BA), Italy.
Saltarella I; Operative Unit of Internal Medicine 'G. Baccelli', Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, Italy.
Solimando AG; Operative Unit of Internal Medicine 'G. Baccelli', Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, Italy.
Gurrado A; Academic General Surgery Unit, Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, (BA), Italy.
Ferraro V; Academic General Surgery Unit, Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, (BA), Italy.
Pasculli A; Academic General Surgery Unit, Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, (BA), Italy.
Sgaramella LI; Academic General Surgery Unit, Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, (BA), Italy.
Racanelli V; Operative Unit of Internal Medicine 'G. Baccelli', Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, Italy.
Vacca A; Operative Unit of Internal Medicine 'G. Baccelli', Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, Italy.
Testini M; Academic General Surgery Unit, Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' Medical School, Bari, (BA), Italy.
Pokaż więcej
Źródło :
Surgery [Surgery] 2021 Jan; Vol. 169 (1), pp. 27-33. Date of Electronic Publication: 2020 May 30.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Thyroidectomy*
Angiogenic Proteins/*blood
Goiter, Nodular/*surgery
Thyroid Cancer, Papillary/*surgery
Thyroid Neoplasms/*surgery
Adult ; Aged ; Biomarkers, Tumor/blood ; Case-Control Studies ; Female ; Goiter, Nodular/blood ; Goiter, Nodular/pathology ; Healthy Volunteers ; Humans ; Male ; Middle Aged ; Postoperative Period ; Preoperative Period ; Prognosis ; Thyroid Cancer, Papillary/blood ; Thyroid Cancer, Papillary/pathology ; Thyroid Gland/pathology ; Thyroid Gland/surgery ; Thyroid Neoplasms/blood ; Thyroid Neoplasms/pathology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Mechanism of Transplanted Islet Engraftment in Visceral White Adipose Tissue.
Autorzy :
Sakata N; Department of Regenerative Medicine and Transplantation, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.; Center for Regenerative Medicine, Fukuoka University Hospital, Fukuoka, Japan.
Yoshimatsu G; Department of Regenerative Medicine and Transplantation, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.; Center for Regenerative Medicine, Fukuoka University Hospital, Fukuoka, Japan.
Tanaka T; Department of Regenerative Medicine and Transplantation, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.; Center for Regenerative Medicine, Fukuoka University Hospital, Fukuoka, Japan.
Yamada T; Department of Regenerative Medicine and Transplantation, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Kawakami R; Department of Regenerative Medicine and Transplantation, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.; Center for Regenerative Medicine, Fukuoka University Hospital, Fukuoka, Japan.
Kodama S; Department of Regenerative Medicine and Transplantation, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.; Center for Regenerative Medicine, Fukuoka University Hospital, Fukuoka, Japan.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Dec; Vol. 104 (12), pp. 2516-2527.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Adhesion*
Graft Survival*
Islets of Langerhans Transplantation*
Neovascularization, Physiologic*
Diabetes Mellitus, Experimental/*surgery
Intra-Abdominal Fat/*surgery
Islets of Langerhans/*surgery
Adiponectin/metabolism ; Angiogenic Proteins/metabolism ; Animals ; Biomarkers/blood ; Blood Glucose/metabolism ; Diabetes Mellitus, Experimental/blood ; Fibronectins/metabolism ; Insulin/blood ; Integrin beta1/metabolism ; Intra-Abdominal Fat/metabolism ; Islets of Langerhans/metabolism ; Male ; Mice, Inbred C57BL ; Signal Transduction
Czasopismo naukowe
Tytuł :
Local intramyocardial delivery of bioglass with alginate hydrogels for post-infarct myocardial regeneration.
Autorzy :
Qi Q; Department of Cardiac Surgery, First Hospital of Lanzhou University, Lanzhou, 730000, China.
Zhu Y; Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Liu G; Department of Cardiology, Yuyao People's Hospital, Yuyao, 315400, China.
Yuan Z; Department of Cardiac Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Li H; Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China. Electronic address: .
Zhao Q; Department of Cardiac Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2020 Sep; Vol. 129, pp. 110382. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Journal Article
MeSH Terms :
Alginates/*chemistry
Angiogenesis Inducing Agents/*pharmacology
Ceramics/*pharmacology
Myocardial Infarction/*drug therapy
Myocytes, Cardiac/*drug effects
Neovascularization, Physiologic/*drug effects
Regeneration/*drug effects
Angiogenesis Inducing Agents/chemistry ; Angiogenic Proteins/genetics ; Angiogenic Proteins/metabolism ; Animals ; Apoptosis/drug effects ; Apoptosis Regulatory Proteins/genetics ; Apoptosis Regulatory Proteins/metabolism ; Cell Line ; Ceramics/chemistry ; Disease Models, Animal ; Drug Compounding ; Human Umbilical Vein Endothelial Cells/drug effects ; Human Umbilical Vein Endothelial Cells/metabolism ; Humans ; Hydrogels ; Myocardial Infarction/metabolism ; Myocardial Infarction/pathology ; Myocardial Infarction/physiopathology ; Myocytes, Cardiac/metabolism ; Myocytes, Cardiac/pathology ; Rats ; Rats, Sprague-Dawley ; Recovery of Function ; Ventricular Function, Left/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies